Ponatinib for CML patients in routine clinical practice: the PONDEROSA study. Schenk T, Fabisch C, Ernst T, Ernst P, et al. Ann Hematol 2026;105:9.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Schenk T, Fabisch C, Ernst T, Ernst P, et al. Ponatinib for CML patients in routine clinical practice: the PONDEROSA study. Ann Hematol 2026;105:9.
PMID: 41535610